Argenx Se (ARGX) Assets Average (2016)

Argenx Se (ARGX) posted Assets Average of $82.3 million for Q4 2016.

Argenx Se (ARGX) Assets Average (2016) Analysis & Trends

Argenx Se's Assets Average history runs 1 years deep, the most recent figure standing at $82.3 million for Q4 2016.

Quarterly Assets Average changed N/A year-over-year to $82.3 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $82.3 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 billion, up 38.53% from the prior year.
Assets Average was $82.3 million for Q4 2016 at Argenx Se.
Across five years, Assets Average topped out at $82.3 million in Q4 2016 and bottomed at $82.3 million in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	303.40 Mn
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	65.01 Mn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	40.89 Mn
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	8.37 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	26.06 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	40.71 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-	795.91 Mn
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	2.30 Bn
10	Alnylam Pharmaceuticals	36.08 Bn	33.07 Bn	959.66 Mn	5.05 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2016	82.29 Mn